Spine (Phila Pa Tai Q, Kirshblum S, Chen B, et al. Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective.
about this topic. Key Words: Spinal cord injury, neuropathic pain, gabapentin, pregabalin. Classification of pain following spinal cord injury. [Show abstract].
Management of neuropathic pain following spinal cord injury (SCI) can be a . decreased following 12 weeks of gabapentin or carbamazepine treatment.
Other antiepileptics that have recently shown promise include lamotrigine, pregabalin, spinao lacosamide. Bethea JR, Dietrich WD. Rest of the chemicals were of analytical grade. Topics in Pain Management. Neuropathic pain is different from nocioceptive pain. The dramatic changes that occur with injury and persistent pain underscore that chronic pain should be considered a disease of the nervous system, not just prolonged acute pain or a symptom of an injury. Strengthening and optimal movements for painful shoulders STOMPS in chronic spinal cord injury: a randomized controlled trial.
PubMed CrossRef Google Scholar Jensen MP, Barber J, Romano Gabapentin neuropathic pain following spinal cord injury, Hanley MA, Raichle KA, Molton IR, et al. Where pain is intractable and does not respond to conventional measures, intrathecal drug delivery or surgical intervention should be considered. My Liebert Connect Email Preference Center. Floating microspheres as drug delivery system: Newer approaches. Sometimes people with spinal cord disorders experience spasms of the hand or leg which occur as constant or intermittent contractions and can be very painful.
Gabapentin neuropathic pain following spinal cord injury - doing
Yang JY, Kim HS, Lee JK. In general, pain assessment in individuals with SCI is complex and requires a combination of standard general pain assessments, as well as medically specific questions unique to the patient's pathophysiology. Santiago , Odrick Rosas , Aranza I. Log In Sign Up It's Free! Randomised, placebo-controlled, double-blind, cross-over. Obtaining direct evidence, such as electrophysiological and neurochemical, of drug effects from patients as performed in animals, is a tremendous technical hurdle.